Block on Trump's Asylum Ban Upheld by Supreme Court
In an antitrust action alleging monopoly leveraging in an HIV drug market, the denial of summary judgment to Defendants is reversed, where allegations of monopoly leveraging through pricing conduct in two markets does not state a claim under Section 2 of the Sherman Act absent an antitrust refusal to deal in the monopoly market or below-cost pricing in the second market.
Argued and Submitted May 13, 2009
Filed July 7, 2009
Opinion by Judge Rymer